|

SHR-3167 Injection Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 1: 2

Top Sponsors

  • Jiangsu HengRui Medicine Co., Ltd.2

Indications

  • Diabetes2
  • Diabetes Mellitus1
  • Type 2 Diabetes1

Other2 trials

A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection
Phase 1
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.